Your browser does not support iframes.
Teva has been awarded a Korn Ferry Employee Engagement Award, recognizing a best-in-class level of engagement in France, Mexico and Poland.
Data presented during the week of 70th World Health Assembly, in Geneva, placed a spotlight on an emerging global public healthcare challenge – the growing burden of managing multiple chronic conditions. The data, presented to a group of renowned public healthcare experts, convened by the International Association of Patient Organizations (IAPO) and Teva, showed a worrying gap in understanding and planning of the management of patients diagnosed with multiple chronic conditions (polychronic).
On June 13th, the National Liberty Museum in Philadelphia hosted an event honoring Richard Egosi, former Teva group EVP and chief legal officer, who passed away in 2016. Friends, family and colleagues gathered to remember Rich and to celebrate the kick off of the Healthcare Heroes Awards program, being sponsored by Teva in his memory.
Ukrainian Prime Minister Volodymyr Groysman recently visited Teva as part of an official visit to Israel.
The opening of the new multi-purpose synthesis plant at Teva’s Croatian site in Savski Marof marks the end of the greatest investment cycle in PLIVA’s history, worth over one billion kuna. The new plant, worth half a billion kuna, will double production capacities in some segments at Savski Marof. More than 95 % of products will be exported to the largest markets around the word.
Pharma Tech Outlook Magazine, an authoritative journal for technological biopharmaceutical developments, published a special edition editorial featuring Guy Hadari, SVP & CIO, Teva Pharmaceuticals.
Teva's German production sites are planning to convert their electricity supplies to 100% renewable energy. By December 2015, they will be using only “green energy”.
In a remarkable achievement, Anna Yarvits, SVP General Manager, Teva Russia & CIS, has been rated as one of the 25 Most Influential Women CEO in Russian Business.
On April 25, a devastating earthquake of 7.9 magnitude hit Nepal and the surrounding areas.
Fourth annual PatientView survey identifies Teva as a “Corporate Star” in the eyes of patients. Making medicines accessible is key to patient groups.
More than 160 employees recently participated in Teva Italia’s V-Day (volunteer-day). The event was held on October 16th at ten different non-profit associations across Italy. The selected organizations deal with key social issues including children from broken families, victims of abuse, families in need of assistance and social integrations of foreign people and the disabled.